blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1509598

EP1509598 - INDUCTION OF INSULIN EXPRESSION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.04.2009
Database last updated on 26.07.2024
Most recent event   Tooltip17.04.2009Application deemed to be withdrawnpublished on 20.05.2009  [2009/21]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
[N/P]
Former [2005/09]For all designated states
The Regents of the University of California
12th Floor, 1111 Franklin Street
Oakland, California 94607-5200 / US
Inventor(s)01 / LEVINE, Fred
2427 Malibu Way
Del Mar, CA 92014 / US
02 / ITKIN-ANSARI, Pamela
1013 Daisy Avenue
Carlsbad, CA 92009 / US
 [2005/09]
Representative(s)Campbell, Patrick John Henry, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2007/24]Campbell, Patrick John Henry, et al
J.A. Kemp & Co., 14 South Square, Gray's Inn
London WC1R 5JJ / GB
Former [2005/21]Jones, Keith William, et al
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2005/09]Buckley, Guy Julian, et al
Castles, 1 King Street
Bakewell, Derbyshire DE45 1DZ / GB
Application number, filing date03757244.301.04.2003
[2005/09]
WO2003US09986
Priority number, dateUS2002016295204.06.2002         Original published format: US 162952
[2005/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03103613
Date:18.12.2003
Language:EN
[2003/51]
Type: A2 Application without search report 
No.:EP1509598
Date:02.03.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 18.12.2003 takes the place of the publication of the European patent application.
[2005/09]
Search report(s)International search report - published on:US01.04.2004
(Supplementary) European search report - dispatched on:EP24.03.2006
ClassificationIPC:C12N5/00, C12N5/02, C12N5/10, C12Q1/02, C12Q1/68
[2005/09]
CPC:
C12N5/0676 (EP,US); A61K31/00 (EP,US); A61K31/165 (EP,US);
A61K31/167 (EP,US); A61K31/18 (EP,US); A61K31/19 (EP,US);
A61K31/192 (EP,US); A61K31/336 (EP,US); A61K31/473 (EP,US);
A61K38/12 (EP,US); A61K38/15 (EP,US); A61K38/2278 (EP,US);
A61K38/26 (EP,US); A61K45/06 (EP,US); G01N33/5052 (EP,US);
C12N2501/70 (EP,US) (-)
C-Set:
A61K31/165, A61K2300/00 (US,EP);
A61K31/167, A61K2300/00 (US,EP);
A61K31/18, A61K2300/00 (US,EP);
A61K31/192, A61K2300/00 (EP,US);
A61K31/19, A61K2300/00 (US,EP);
A61K31/336, A61K2300/00 (EP,US);
A61K31/473, A61K2300/00 (EP,US);
A61K38/12, A61K2300/00 (EP,US);
A61K38/2278, A61K2300/00 (EP,US);
A61K38/26, A61K2300/00 (US,EP)
(-)
Designated contracting statesDE,   FR,   GB [2005/38]
Former [2005/09]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:INDUKTION DER INSULINEXPRESSION[2005/09]
English:INDUCTION OF INSULIN EXPRESSION[2005/09]
French:INDUCTION DE L'EXPRESSION DE L'INSULINE[2005/09]
Entry into regional phase19.10.2004National basic fee paid 
19.10.2004Search fee paid 
19.10.2004Designation fee(s) paid 
19.10.2004Examination fee paid 
Examination procedure19.10.2004Examination requested  [2005/09]
11.01.2007Despatch of a communication from the examining division (Time limit: M06)
23.07.2007Reply to a communication from the examining division
02.10.2008Despatch of a communication from the examining division (Time limit: M04)
31.10.2008Application deemed to be withdrawn, date of legal effect  [2009/21]
29.12.2008Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2009/21]
Fees paidRenewal fee
19.10.2004Renewal fee patent year 03
26.04.2006Renewal fee patent year 04
27.04.2007Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.04.200806   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]US5424286  (ENG JOHN [US]) [YD] 11-14,36-39 * column 1 - column 2 *;
 [XY]US6326201  (FUNG BRENDA [US], et al) [X] 1,2,6-10,15-17,29,31-33,40-44 * column 3 - column 4 * * column 33 * * claims 1-39 * [Y] 3-5,11-14,30,34-39;
 [Y]  - JORGENSEN M C ET AL, "Cloning and DNA-binding properties of the rat pancreatic beta-cell-specific factor Nkx6.1", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, (19991119), vol. 461, no. 3, ISSN 0014-5793, pages 287 - 294, XP004260565 [Y] 3-5,11-14,30,34-39 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0014-5793(99)01436-2
 [YD]  - NAYA F J ET AL, "TISSUE-SPECIFIC REGULATION OF THE INSULIN GENE BY A NOVEL BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR", GENES AND DEVELOPMENT, COLD SPRING HARBOR, NY, US, (19950415), vol. 9, no. 8, ISSN 0890-9369, pages 1009 - 1019, XP001007925 [YD] 4,5,34,35 * the whole document *
 [YD]  - WU KUO-LIANG ET AL, "Hepatocyte nuclear factor 3-beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene", MOLECULAR AND CELLULAR BIOLOGY, (1997), vol. 17, no. 10, ISSN 0270-7306, pages 6002 - 6013, XP002370367 [YD] 3,30 * the whole document *
 [A]  - HU JI-FAN ET AL, "The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (19981020), vol. 251, no. 2, ISSN 0006-291X, pages 403 - 408, XP002370368 [A] * the whole document *

DOI:   http://dx.doi.org/10.1006/bbrc.1998.9401
 [AD]  - MARKS P A ET AL, "HISTONE DEACETYLASE INHIBITORS AS NEW CANCER DRUGS", CURRENT OPINION IN ONCOLOGY, CURRENT SCIENCE LTD, US, (2001), vol. 13, no. 6, ISSN 1040-8746, pages 477 - 483, XP009010050 [AD] * the whole document *

DOI:   http://dx.doi.org/10.1097/00001622-200111000-00010
 [AD]  - SALAPATEK ANNE MARIE F ET AL, "Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells", MOLECULAR ENDOCRINOLOGY, (199908), vol. 13, no. 8, ISSN 0888-8809, pages 1305 - 1317, XP002370369 [AD] * abstract *

DOI:   http://dx.doi.org/10.1210/me.13.8.1305
 [AD]  - HALVORSEN T L ET AL, "TELOMERASE ACTIVITY IS SUFFICIENT TO ALLOW TRANSFORMED CELLS TO ESCAPE FROM CRISIS", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, (199903), vol. 19, no. 3, ISSN 0270-7306, pages 1864 - 1870, XP002942532 [AD] * the whole document *
International search[Y]US5614492  (HABENER JOEL F [US], et al);
 [Y]US5695995  (WEINTRAUB HAROLD M [US], et al);
 [X]US6326201  (FUNG BRENDA [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.